Intra-aortal augmentation is critical for treating cardiogenic shock and vital for patient survival. The existing systems do meet this requirement adequately. However, they are bulky and hinder patient mobility. The equipment’s cost, availability, and size hinder its penetration to the masses where such occurrences persist, and minimal support is available.
The magnetic pump innovation makes the device portable and enables mobility. It also reduces the inventory carrying cost by 60-70%, making the appliance accessible and penetrating deeper into developing markets.
In order to gain and maintain market leadership in such cutting-edge and life-saving types of equipment, innovations must continue to make it increasingly affordable and versatile. The magnetic pump innovation achieves both affordability and versatility and will allow the first-mover to stay ahead of the market.
Thus, using a magnetic pump is a significant step in providing trigger-based augmentation of fluid flow in the body using IABP with specific applications to the cardiac cycle in a portable form factor and at a lower cost. The reduced weight of the device allows long-term therapy patients to carry the device with them in a small bag, thus improving their quality of life.
